The "Virtual" Reality of Drug Discovery at Novartis
Thursday, October 21st, 2021
8 am PST / 11 am EST / 5pm CET
RSVP Now
The "Virtual" Reality of Drug Discovery at Novartis
A conversation between Edgardo Leija, Chief Experience Officer at Nanome, and Wilian Cortopassi, Senior Expert in Data Science I (Principal Scientist I) at Novartis Institutes for BioMedical Research (NIBR).
Wilian Cortopassi
Senior Expert in Data Science I (Principal Scientist I) at Novartis Institutes for BioMedical Research (NIBR)
Edgardo Leija
Chief Experience Officer at Nanome
What will you learn?
Join our speakers for a discussion and Q&A about the "virtual" reality of drug discovery at Novartis:
How Novartis is using Virtual Reality across different research sites globally (US and Switzerland)
A case study of the main protease (Mpro) of SARS-CoV-2
_edited-1.jpg){kind=icon}
.png?width=185&height=30&name=Nanome_Logo_Horizontal-Black%20(1).png "Nanome_Logo_Horizontal-Black (1)"){kind=logo}